Zeria Pharmaceutical Co (TSE:4559) EPS (Basic) : 円175.39 (TTM As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Zeria Pharmaceutical Co EPS (Basic)?

Zeria Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was 円68.66. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was 円175.39.

Zeria Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2023 was 円68.66. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円175.39.

Zeria Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2023 was 円71.69. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 156.82.

During the past 12 months, Zeria Pharmaceutical Co's average EPS without NRIGrowth Rate was 6.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 41.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 30.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zeria Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 53.60% per year. The lowest was -19.20% per year. And the median was 7.70% per year.

Zeria Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Zeria Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeria Pharmaceutical Co EPS (Basic) Chart

Zeria Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

62.62

68.22

87.76

140.26

175.39

Zeria Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															4.95	66.14	56.29	68.66	-15.70

Zeria Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zeria Pharmaceutical Co's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(7731.262	-	0)	/	44.080
	=	175.39

Zeria Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3026.555	-	0)	/	44.080
	=	68.66

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円175.39

Zeria Pharmaceutical Co (TSE:4559) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Zeria Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Zeria Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zeria Pharmaceutical Co (TSE:4559) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zeria Pharmaceutical Co Ltd (TSE:4559) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351

Website

http://www.zeria.co.jp

Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.

Zeria Pharmaceutical Co (TSE:4559) Headlines

No Headlines